Alcohol, AIDS and Liver Disease: Preventable Side-Effects of Antiretroviral Therapy (R21 award mechanism)
Published Date
Agency
CFDA
93.273
Contact Information
NIH OER Webmaster, FBOWebmaster@OD.NIH.GOV
Deadline
Department
Eligiblity
Nonprofit, for-profit and tribal organizations, institutions of higher education, state, local and tribal governments, independent school districts, and public and Indian housing authorities
Guide Page Reference
None
Program Area
Programe Purpose
To stimulate research on new preventive and therapeutic approaches to alcohol- and antiretroviral drug-induced liver disease in patients with AIDS
